Richard (Alex) Harbison, M.D., M.S. is a fellowship-trained otolaryngologist–head and neck surgeon specializing in thyroid and parathyroid surgical pathology including benign thyroid disease, thyroid cancer, Graves’ disease and hyperparathyroidism. He has special interest across the spectrum of benign thyroid and parathyroid disease, leveraging state-of-the-art technology including scarless thyroidectomy and minimally invasive radiofrequency ablation (RFA). Of notable interest to Dr. Harbison is the treatment of advanced thyroid cancer in the setting of a multidisciplinary team including endocrinologists, medical and radiation oncologists, and speech and language pathologists.
Dr. Harbison obtained his medical degree at the University of Colorado School of Medicine. He completed his residency in otolaryngology–head and neck surgery at the University of Washington School of Medicine and pursued fellowship training at the Johns Hopkins University School of Medicine, where he completed a research fellowship in immunology followed by a fellowship in head and neck surgical oncology.
Dr. Harbison’s research interests include leveraging metabolism to regulate immune responses. Specifically, he seeks to improve anti-tumor immune responses in thyroid and other head and neck cancers.